[Federal Register: April 25, 2006 (Volume 71, Number 79)]
[Notices]
[Page 23948]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ap06-115]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 20, 2005, August 4, 2005
and September 2, 2005, Cody Laboratories, Inc., 601 Yellowstone Avenue,
Cody, Wyoming 82414, made application by letters to the Drug
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Methadone (9250)........................... II
Alfentanil (9737).......................... II
------------------------------------------------------------------------
The company plans to manufacture in bulk, for distribution to its
customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than June 26, 2006.
Dated: April 18, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-6115 Filed 4-24-06; 8:45 am]
BILLING CODE 4410-09-P